Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Empagliflozin does not rescue nor exacerbate doxorubicin-induced skeletal muscle wasting and metabolic dysfunction in male mice
Related
- Empagliflozin and Metformin Combination Therapy Attenuates Oxidative Stress and Inflammation in Experimental Cardio–Kidney–Metabolic Syndrome
- The Mitophagy Vortex: Bridging Inflammatory, Oxidative, Hypoxic, and Aging Insults to Drive COPD Skeletal Muscle Dysfunction
- Metabolic reprogramming of CCR2+ MHC IIhigh macrophage contributes to myocarditis induced by Doxorubicin
- Exercise training does not mitigate high-phosphate diet-induced mitochondrial dysfunction in skeletal muscle in male mice.
- Effect of human milk oligosaccharide on the liver-skeletal muscle axis in streptozotocin-induced metabolic stress
BibTeX
@article{asbroeck2026empagliflozin,
title = {{Empagliflozin does not rescue nor exacerbate doxorubicin-induced skeletal muscle wasting and metabolic dysfunction in male mice}},
author = {Birgit Van Asbroeck and Dorien Dombrecht and Sebastiaan Dalle and Emeline M. Van Craenenbroeck and Pieter-Jan Guns and Eric van Breda},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73763-6},
url = {https://www.nature.com/articles/s41598-026-73763-6},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Empagliflozin does not rescue nor exacerbate doxorubicin-induced skeletal muscle wasting and metabolic dysfunction in male mice
AU - Birgit Van Asbroeck
AU - Dorien Dombrecht
AU - Sebastiaan Dalle
AU - Emeline M. Van Craenenbroeck
AU - Pieter-Jan Guns
AU - Eric van Breda
PY - 2026
DA - 2026/10/22
JO - Scientific Reports
DO - 10.1038/s41598-026-73763-6
UR - https://www.nature.com/articles/s41598-026-73763-6
SN - 2045-2322
ER -